You are here

Gender and the Genome

Gender and the Genome

Published in Association with The Foundation for Gender-Specific Medicine

eISSN: 24702900 | ISSN: 24702897 | Current volume: 4 | Current issue: 1

Gender and the Genome is a peer-reviewed open access journal that explores how the new science of the 21st century is profoundly influenced by biological sex. Through evidence-based original research, reviews, perspectives, and commentaries, the Journal illuminates the impact of biological sex on technology and its effects on human life. The Journal’s international editorial board is comprised of the most forward-thinking leaders in gender-specific medicine to engage the community of molecular biologists, engineers, ethicists, anthropologists, and legal experts in a dialogue about the nature and implications of 21st century technology.

Gender and the Genome coverage includes:

  • Sex-specific differences in genomic, cellular, tissue, and whole animal function
  • New life forms generated by synthetic biology
  • Technological advances meant to enhance the function in humans, whether compromised by disease/injury or in normal individuals
  • Manufacture and usefulness of robotic devices
  • Commentaries by ethicists, theologians, anthropologists, epidemiologists, and sociologists/social scientists on the achievements of 21st century science to alter the genome, create new life forms, and develop technologically enhanced humans

Gender and the Genome is under the editorial leadership of Editor-in-Chief Marianne J. Legato, MD, PhD (hon. c.), FACP, Emerita Professor of Clinical Medicine, Columbia University; Adjunct Professor of Medicine, Johns Hopkins School of Medicine; and Founder, Foundation for Gender-Specific Medicine; and other leading investigators.

Gender and the Genome is the Official Journal of The Foundation for Gender-Specific Medicine.  


Open access article processing charge (APC) information

The APC for this journal is currently 750 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.


Submit your manuscript today at http://mc.manuscriptcentral.com/gng


Contact

Please direct any enquiries to kiley.allen@sagepub.com

In the last two decades, following the description of the structure of the human genome, gender-specific medicine is evolving in precise and exciting detail at the molecular level. Gender and the Genome specifically aims to publish the new findings about the molecular biology that will eventually underlie at least the best approximation we can offer of personalized, gender-specific medicine. The journal is open access, fully peer-reviewed and the official journal of the Foundation for Gender-Specific Medicine. We are soliciting basic research at the molecular level that expands our understanding of the physiological and environmental components that shape the individual.

Gender and the Genome’s mission is to a resource for molecular biologists, clinicians and physicians, the legal and ethical community, sociologists and epidemiologists, and the young, untenured scientist engaged in gender-specific medicine. It is our hope that as our skills at defining molecular biology expand, our audience will deploy this new biology ever more effectively to maintain health, prevent disease and treat the sick patient. Bringing molecular genetic mechanisms to the bedside is our ultimate goal.

The journal currently accepts original research, reviews, brief communications, commentaries and letters to the editor. Topics of interest include, but are not limited to:

  • Legal and ethical views on significant therapeutic proposals or interventions
  • The importance of the environment in human variability from a sociological and epidemiological point of view
  • Identification of specific elements in gene regulation
  • Impact of biological sex on gene expression
  • Mechanisms by which environmental experience impact gene regulation
  • Transmission of epigenetic features of the genome to subsequent generations
  • Insight into whether gene mutation or epigenetic modification create an observed departure from normal physiology
  • How genetic or epigenetic manipulation can be translated to patient care

 

Editor
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA
Editor in Chief
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA
Steering Committee
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Marjorie R. Jenkins, MD, MEHP, FACP Texas Tech University Health Sciences Center, Food and Drug Administration, Silver Spring, MD, USA
Justin P. Killian, Esq. The Foundation for Gender-Specific Medicine, New York, NY, USA
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA
Alyson J. McGregor, MD, MA, FACEP Warren Alpert Medical School, Brown University, Providence, RI, USA
Virginia M. Miller, PhD Mayo Clinic, Rochester, MN
Jane F. Reckelhoff, PhD University of Mississippi Medical Center, Jackson, MS, USA
Associate Editors
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Editorial Board
Fernando Abad-Franch, MD, PhD Centro de Pesquisa René Rachou - Fiocruz, Belo Horizonte, Brazil
Thurayya Arayssi, MD, FACP, FACR, FRCP Weill Cornell Medicine - Qatar, Doha, Qatar
Arthur P. Arnold, PhD University of California, Los Angeles, Los Angeles, CA, USA
Hrayr P. Attarian, MD, FACCP, FAASM Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Giovannella Baggio, MD University of Padua, Padua, Italy
Neil A. Bradbury, PhD Chicago Medical School, Chicago, IL, USA
Eliza Chin, MD, MPH American Medical Women's Association, Reston, VA, USA
Aaron Ciechanover, MD, DSc The Technion Institute, Israel
Terri L. Cornelison, MD, PhD, FACOG U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Gayatri Devi, MD, FAAN, FACP State University of New York at Downstate, New York, NY, USA
Adrian S. Dobs, MD, MHS The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Gillian Einstein, PhD University of Toronto, Toronto, ON, Canada
Dov Feldberg, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Camilo Fernandez, MD, MSc, MBA, MCTS, FASH, FASE H.L. Brighton Center for Advanced Cardiovascular Diagnostics, Brighton, MA, USA
Robert C. Froemke, PhD New York University School of Medicine, New York, NY, USA
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Marjorie R. Jenkins, MD, MEHP, FACP Texas Tech University Health Sciences Center, Food and Drug Administration, Silver Spring, MD, USA
Paula A. Johnson, MD, MPH Wellesley College, Wellesley, MA
Alexandra Kautzky-Willer, MD Medical University Vienna, Vienna, Austria
Jasna Markovac, PhD California Institute of Technology, Pasadena, CA, USA
Alyson J. McGregor, MD, MA, FACEP Warren Alpert Medical School, Brown University, Providence, RI, USA
Virginia M. Miller, PhD Mayo Clinic, Rochester, MN
Maria Grazia Modena Universitá Di Modena E Reggio Emilia, Modena, Italy
Padmaja Mummaneni, PhD Regulatory Scientist, Bethesda, MD
Pamela Ouyang, MBBS, MD The Johns Hopkins University School of Medicine, Baltimore, MD
Ingrid Perscky, MD Global Men's Health Foundation, Panama City, Panama
Vivian W. Pinn, MD Fogarty International Center at NIH, Bethesda, MD, USA
Jane F. Reckelhoff, PhD University of Mississippi Medical Center, Jackson, MS, USA
Vera Regitz-Zagrosek, MD, PhD Charité - Universitätsmedizin Berlin, Berlin, Germany
Basmah Safdar, MD, MSc Yale University School of Medicine, New Haven, CT, USA
Ibis Sánchez-Serrano, MALD, BSc The Core Model Corporation, S.A., Panama City, Panama
Karin Schenck-Gustafsson, MD, PhD, FESC Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Hiroaki Shimokawa, MD, PhD Tohoku University Graduate School of Medicine, Sendai, Japan
Francoise L. Simon, PhD Mount Sinai School of Medicine, Columbia University, New York, NY, USA
Jeanette Strametz-Juranek, MD Medical University of Vienna, Vienna, Austria
Kimberly J. Templeton, MD University of Kansas Medical Center, Kansas City, KS, USA
Janice Werbinski, MD Western Michigan University Homer Stryker School of Medicine, Kalamazoo, MI, USA
  • Directory of Open Access Journals (DOAJ)
  • This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Gender and the Genome will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
    SUBMIT MANUSCRIPT

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplemental material
      6.4 Reference style
      6.5 English language editing services
      6.6 Units, nomenclature, and abbreviations
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

    1. Open Access

    Gender and the Genome is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.

    The APC for this journal is currently $750 USD.

    The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Gender and the Genome, please ensure you have read the Aims & Scope.

    3.2 Article types

    Word limits do not include the title, abstract, figure legends, references,
    acknowledgments, or disclosure statements.

    • Original Articles: 3500 words
    • Review Articles: 8,000 words
    • Brief Communications: 1,500 words
    • Commentaries: 1,000 words
    • Letter to the Editor: 500 words

    Title Page (Required).

    The title page of your submission, and the abstract, must be included as part of
    your main text document
    (not as separate files). The title page must include the
    following items:

    • The complete title of the article (title should not exceed 15-18 words)
    • All contributing authors’ full names, complete affiliation and mailing address,
      and valid email addresses
    • A brief running title (no more than 50 characters, including spaces)
    • The corresponding author’s complete contact information including
      postal address and current e-mail address.
    • A minimum of four keywords to assist in the peer-review process.

    Abstract. For all original and review papers, the next page of the manuscript should consist of
    an abstract of no more than 400 words. Abstracts should be structured as follows:

    Original Research: Introduction, Objectives, Methods, Results, and Conclusion.

    Review articles: Introduction, Significance, Results, Conclusion

    References, proprietary, and trade names are not permitted in the abstract.

    Keywords. Please provide a minimum of four keywords below the abstract.

    Text. The text of the manuscript should follow this format for Original Research:

    Abstract
    Introduction
    Objectives
    Methods
    Results
    Conclusion
    Acknowledgments
    Author Disclosure Statement
    Ethics statements (including Conflict of Interest, an informed consent statement, an animal and/or human rights statement and an IRB approval statement)
    References

    For Review articles, the following format should be followed:

    Abstract
    Introduction
    Significance
    Results
    Conclusion
    Acknowledgments
    Author Disclosure Statement
    Ethics statements (including Conflict of Interest)
    References

    All manuscripts should be double-spaced.

    For all material sources, such as devices, drugs, etc., indicate manufacturer/supplier name,
    city, state, and country.

    Footnotes. Use of footnotes is discouraged. If footnotes are necessary, prepare footnotes
    double-spaced on a separate page within the main text file of your submission.

    Acknowledgments. Collaborations, sources of research funds, and other acknowledgments
    should be listed in a separate section at the end of the text ahead of the References section.

    Author Disclosure Statement. Immediately following the Acknowledgments section, include a
    header entitled, “Author Disclosure Statement.” All authors are expected to disclose any
    institutional or commercial affiliations that might pose a conflict of interest regarding the
    publication of a manuscript. Institutional affiliations, as indicated on the title page, should include
    all corporate affiliations and any funding sources that support the work. Other types of affiliation,
    including consultancies, honoraria, stock ownership, equity interests, arrangements regarding
    patents, or other vested interests should also be disclosed in the Disclosure section.

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    Gender and the Genome utilizes a single-blind peer review process in which the reviewer’s name and information is withheld from the author.

    Gender and the Genome is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Gender and the Genome can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

    4.4 Funding

    Gender and the Genome requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Gender and the Genome to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    4.7 Clinical trials

    Gender and the Genome endorses the ICMJE requirement that clinical trials are registered in a WHO approved public trials registry at or before the time of first patient enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    5.1.1 Plagiarism

    Gender and the Genome and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    5.1.2 Prior Publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

           5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Gender and the Genome publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial, which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    For the main text document, upload in Microsoft Word format. If you have a PDF copy to upload, please ensure that you also upload the Word version. Word templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online.

    Photographic illustrations should be rendered with at least 300 dpi; please use CMYK color conversion if possible. Graphs made with Office software such as Microsoft Excel, can be provided in their original format to facilitate conversion into printable format with preserved quality. Any other line graphs/illustrations should preferably be provided in EPS format with a resolution of at least 600 dpi to prevent ragged lines when printed. A figure image should be at least 160 mm in width at the appropriate resolution. For further guidance on how to prepare your digital image see here.

    Graphs and images that are unsuitable may be returned to the author for amendment, causing delay in publication.

    6.3 Supplemental material

    This journal is able to host additional materials online (e.g. datasets, videos, images etc.) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.

    6.4 Reference style

    Gender and the Genome adheres to the AMA reference style. View the AMA guidelines to ensure your manuscript conforms to this reference style.

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services for further information.

    6.6 Units, nomenclature, and abbreviations

    Units of measurement: should be expressed in SI and metric units; older conventional units may be added in parentheses.

    Nomenclature: use the generic or chemical name of any drug, in lower case; the specific trade name (capitalized) may be given in parentheses after the first text reference.

    Standard abbreviations and symbols: should be used then defined in full in the first instance unless they are standard units of measurement. Avoid any use of abbreviations in the article title and abstract.

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    To submit your manuscript to Gender and the Genome, please visit our manuscript submission site.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.

    7.5 Permissions

    Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author via our editing portal SAGE Edit, or by email to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos.

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Gender and the Genome editorial office as follows:

    Isabella Benita
    Email: Isabella@gendermed.org

    Back to top